HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thymopentin reduces the susceptibility of aged mice to cutaneous leishmaniasis by modulating CD4 T-cell subsets.

Abstract
BALB/c mice are highly susceptible to Leishmania major infection. The susceptibility increases progressively with the age of the mice. Aged mice produce progressively lower levels of interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) but higher levels of IL-4 compared to younger mice. Thymopentin, a pentapeptide with thymopoietin activity, dramatically increases the resistance to Leishmania major infection in aged mice. The thymopentin-treated mice produce enhanced levels of IL-2 and IFN-gamma, but significantly reduced amounts of IL-4. Thus, it appears that the age-related susceptibility to cutaneous leishmaniasis is correlated with the enhancement of Th2 and the reduction of Th1 cell activities. Furthermore, thymic hormone may play an important role in the induction and function of these two subsets of CD4 T cells.
AuthorsE Cillari, S Milano, M Dieli, F Arcoleo, R Perego, F Leoni, G Gromo, A Severn, F Y Liew
JournalImmunology (Immunology) Vol. 76 Issue 3 Pg. 362-6 (Jul 1992) ISSN: 0019-2805 [Print] England
PMID1356094 (Publication Type: Journal Article)
Chemical References
  • Interleukin-2
  • Interleukin-4
  • Interferon-gamma
  • Thymopentin
Topics
  • Age Factors
  • Aging (immunology)
  • Animals
  • CD4-Positive T-Lymphocytes (drug effects, metabolism)
  • Disease Susceptibility
  • Female
  • Interferon-gamma (biosynthesis)
  • Interleukin-2 (biosynthesis)
  • Interleukin-4 (metabolism)
  • Leishmaniasis, Cutaneous (immunology, prevention & control)
  • Lymph Nodes (immunology)
  • Mice
  • Mice, Inbred BALB C
  • Spleen (metabolism)
  • Thymopentin (pharmacology, therapeutic use)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: